BioPharma Credit (LON:BPCR – Get Free Report) shares were down 0.8% during mid-day trading on Thursday. The company traded as low as GBX 0.97 and last traded at GBX 0.97. Approximately 6,336,127 shares traded hands during mid-day trading, an increase of 331% from the average daily volume of 1,469,651 shares. The stock had previously closed at GBX 0.98.
BioPharma Credit Stock Performance
The stock has a market capitalization of £10.91 million, a P/E ratio of 0.10 and a beta of 0.23. The firm has a 50-day moving average price of GBX 0.97 and a 200 day moving average price of GBX 0.96.
Insider Transactions at BioPharma Credit
In other news, insider Graeme Proudfoot bought 70,000 shares of the business’s stock in a transaction on Tuesday, September 29th. The stock was acquired at an average price of GBX 99 per share, with a total value of £69,300. 0.09% of the stock is currently owned by corporate insiders.
BioPharma Credit Company Profile
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
Further Reading
- Five stocks we like better than BioPharma Credit
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
